Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
Why Silencing Food Noise Requires More Than Ozempic - Featured image
Metabolic Health

Why Silencing Food Noise Requires More Than Ozempic

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·February 17, 2026·6 min read

On this page

  • Understanding Food Noise in a Weight-Obsessed Culture
  • The Rise of Ozempic and GLP-1 Medications
  • Experts Bronwyn Wood and Courtney Nelson: A Shared Philosophy
  • Workshops for GPs and Clinicians: Broadening the Lens
  • Size-Inclusive Care and Body Neutrality
  • What This Means for Patients Considering Ozempic or GLP-1 Therapy
  • Key Takeaways
  • Conclusion: A Holistic Path to Silencing Food Noise
  • What Causes Food Noise?
  • Safety Considerations with GLP-1 Agonists
  • Addressing Overlooked Factors
  • Body Neutrality vs. Positivity

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Food noise isn't just hunger—it's exhausting mental commentary on dieting, body image, and worthiness shaped by culture. While Ozempic and GLP-1 agonists like Wegovy promise relief, clinicians Bronwyn Wood and Courtney Nelson argue for a broader approach. Their workshops challenge weight-centric care to foster true silencing through body neutrality and informed prescribing.

Share

On this page

  • Understanding Food Noise in a Weight-Obsessed Culture
  • The Rise of Ozempic and GLP-1 Medications
  • Experts Bronwyn Wood and Courtney Nelson: A Shared Philosophy
  • Workshops for GPs and Clinicians: Broadening the Lens
  • Size-Inclusive Care and Body Neutrality
  • What This Means for Patients Considering Ozempic or GLP-1 Therapy
  • Key Takeaways
  • Conclusion: A Holistic Path to Silencing Food Noise
  • What Causes Food Noise?
  • Safety Considerations with GLP-1 Agonists
  • Addressing Overlooked Factors
  • Body Neutrality vs. Positivity

Understanding Food Noise in a Weight-Obsessed Culture

Food noise is rarely just about food. It manifests as the constant mental commentary: what should I eat, what shouldn't I eat, have I done 'enough' to earn this, how does my body look today? This reflects a culture deeply invested in weight and appearance. Bronwyn Wood, a credentialed eating disorder clinician (CEDC), has seen it time and time again in her clinical work spanning body image concerns, chronic dieting, disordered eating, and more severe eating disorders.

She notes how normalized this mental noise has become, particularly among women due to society's appearance-based focus. 'For many clients, the starting point isn't a diagnosis. It's exhaustion,' she said. This exhaustion stems from years of believing there's one 'right' way to eat, one 'acceptable' body size, one number that determines health. Wood's goal is to help people break that cycle, realizing they've been told this is the only way.

What Causes Food Noise?

Food noise often arises from chronic dieting, societal pressures, and internalized weight stigma. It's not merely a lack of willpower but a psychological loop reinforced by media, marketing, and even healthcare advice. GLP-1 receptor agonists like Ozempic (semaglutide) and Wegovy can physically quiet appetite signals by mimicking gut hormones that slow gastric emptying and signal fullness to the brain, potentially reducing some hunger-related thoughts. However, they don't address the deeper cultural and emotional roots.

The Rise of Ozempic and GLP-1 Medications

With the rapid rise of GLP-1 receptor agonists such as Wegovy and Ozempic—originally developed for type 2 diabetes—weight loss medications have moved from specialist settings into mainstream conversation. Social media has amplified their visibility, often framing them as a breakthrough solution. These drugs work by activating GLP-1 receptors, which regulate blood sugar, slow digestion, and curb appetite, leading to significant weight loss in clinical trials for obesity and diabetes.

While effective for some, experts caution against viewing them as a universal answer for silencing food noise. Ms Wood is careful not to position the conversation as anti-medication, because for some patients, GLP-1 medications may play a clinically appropriate role. But she highlights vulnerabilities: 'I think a lot of people can be more vulnerable or more at risk in times where their bodies might be changing. That could be perimenopause or menopause around adolescence and childbirth. It's not just bodies, but just changes and stresses in life.'

Safety Considerations with GLP-1 Agonists

Common side effects include nausea, vomiting, and gastrointestinal issues, with rarer risks like pancreatitis or thyroid concerns. Long-term data is emerging, emphasizing the need for monitoring. Patients should discuss family history of eating disorders, mental health, and realistic expectations with providers before starting.

Experts Bronwyn Wood and Courtney Nelson: A Shared Philosophy

Bronwyn Wood and her dietitian colleague Courtney Nelson are not only working one-on-one with clients but turning their attention to the broader healthcare system. Both credentialed eating disorder clinicians (CEDC), they share a philosophy: 'We have the same working philosophy,' Ms Nelson said. 'More broadly, we're both credentialed eating disorder clinicians.'

Ms Wood emphasizes that people can develop eating disorders at any stage of life, making trained experts more 'helpful than harmful.' Their approach challenges the default reliance on weight-centric care, including the growing push toward prescribing weight loss medications as a first-line response. Their message is not anti-medicine, but clear: there needs to be more to the conversation.

'A lot of what I do is try to help people break that cycle and go, "Oh, do you know what? I've been told that this is what I've had to do, and this is the only way".'

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play
Bronwyn Wood, CEDC

Workshops for GPs and Clinicians: Broadening the Lens

Through educational workshops for GPs, medical professionals, and exercise practitioners, Wood and Nelson promote a holistic view. They don't argue medication should never be used but ask clinicians to broaden the lens: Is the patient informed about risks and long-term considerations? Has weight stigma been addressed? Are they focusing on sustainable health behaviors rather than a number on a chart?

'I think when doctors equate people to a number, particularly on the BMI, it's just really unhelpful,' Wood said. Central to the workshops is creating 'a space where it's safe for people to be curious'—to acknowledge internal biases, question assumptions, and examine whether automatically equating higher weight with poor health serves patients effectively.

Addressing Overlooked Factors

When healthcare reduces a person to a number or reflexively moves toward weight loss, it overlooks psychological wellbeing, eating behaviors, socioeconomic factors, trauma history, and the well-documented impact of weight stigma. Ms Nelson sees clients from age 12 and up struggling with diets: 'When we're dieting and treating our body as something that needs to be smaller and be different and change, we're not really connected with it.'

Size-Inclusive Care and Body Neutrality

Size-inclusive care is critical here. 'A lot of it is about people reconnecting and understanding that bodies are diverse and they come in all shapes and sizes,' Nelson said. 'It might be loving or it could be accepting and neutral.'

They steer toward body neutrality over body positivity, which can be hijacked by weight loss communities. 'I think what we do is really a different layer... It's not so much about loving our bodies. It's more than that and in recognising that the drive for thinness and the pressure for that can actually be really harmful and that it's not really related to health. I think acceptance and neutrality, body neutrality, is where we more go. Everyone's different in that, and it's a different journey for everyone.'

Body Neutrality vs. Positivity

Body neutrality focuses on function over aesthetics—appreciating what your body does rather than how it looks. This contrasts with positivity's emphasis on love, which may not resonate during transitions. It supports metabolic health by reducing stress-eating cycles tied to appearance anxiety.

What This Means for Patients Considering Ozempic or GLP-1 Therapy

If food noise is overwhelming your daily life, start by assessing root causes. Discuss with your doctor:

  • Any history of disordered eating or body image issues.
  • Life stage vulnerabilities like perimenopause or postpartum changes.
  • Alternatives like therapy or nutrition counseling before meds.
  • Tools for tracking, such as apps like Shotlee for monitoring symptoms, side effects, or eating patterns alongside GLP-1 use.

Compare GLP-1s to lifestyle interventions: While meds offer rapid appetite suppression, behavioral therapies build lasting skills for silencing noise mentally. For type 2 diabetes patients, Ozempic's glucose benefits are proven, but weight loss alone isn't health.

Key Takeaways

  • Food noise stems from cultural pressures, not just biology—Ozempic quiets physical hunger but not mental chatter.
  • Experts like Wood and Nelson train clinicians via workshops to prioritize size-inclusive, stigma-free care.
  • GLP-1 meds like Wegovy/Ozempic have a role but aren't first-line; screen for eating disorder risks.
  • Embrace body neutrality for reconnection; everyone's path differs.
  • Healthcare should address exhaustion, biases, and sustainable behaviors over BMI numbers.

Conclusion: A Holistic Path to Silencing Food Noise

Silencing food noise requires addressing the full spectrum—from psychological cycles to systemic biases—not just a prescription for Ozempic. By integrating expert insights from clinicians like Bronwyn Wood and Courtney Nelson, patients and providers can foster genuine metabolic health and wellbeing. Consult your healthcare team for personalized guidance, ensuring any GLP-1 therapy complements broader strategies for long-term peace with food and body.

Source Information

Originally published by The Border Mail.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks
Health & Wellness

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks

The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.

8 min read
Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure
Health & Wellness

Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure

GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.

8 min read
Wegovy Pill Arrives in the UK: A New Era for Weight Management?
Health & Wellness

Wegovy Pill Arrives in the UK: A New Era for Weight Management?

The UK has officially approved a pill version of the popular Wegovy weight-loss drug, marking a significant advancement in accessible obesity treatment. This development offers a convenient alternative to weekly injections for many.

6 min read

Same topic: Food Noise

All Food Noise articles →
Could Ozempic and GLP-1s Help ADHD Symptoms?
GLP-1 Medications

Could Ozempic and GLP-1s Help ADHD Symptoms?

People with ADHD report feeling calmer and more focused on GLP-1 drugs like Ozempic, originally for obesity and diabetes. Experts explain potential links to dopamine and reduced food cravings, but stress no clinical trials prove direct benefits. Find out the real story behind social media buzz and what to discuss with your doctor.

5 min read
GLP-1 RAs Reduce Food Noise by 46%, Emerging Evidence Shows
GLP-1 Medications

GLP-1 RAs Reduce Food Noise by 46%, Emerging Evidence Shows

Emerging evidence suggests GLP-1 receptor agonists (GLP-1 RAs) not only aid weight loss but also significantly quiet 'food noise'—those persistent, distressing thoughts about food. In the US-based INFORM survey, 550 individuals using GLP-1s reported a 46% reduction in constant food thoughts, alongside mental health gains. This could redefine obesity management for better holistic outcomes.

6 min read
Woman Pays £200/Month for Life After Quitting Mounjaro
GLP-1 Medications

Woman Pays £200/Month for Life After Quitting Mounjaro

A woman who shed over four stone on Mounjaro regained weight rapidly after quitting due to overwhelming food noise. She returned to the drug at 5mg, committing to £200 monthly for life to sustain her size 12 figure. Her story highlights GLP-1 challenges in long-term weight management.

2 min read

More in Metabolic Health

Serena Williams Champions GLP-1s: Ads Air Amidst Tennis Comeback
Health & Wellness

Serena Williams Champions GLP-1s: Ads Air Amidst Tennis Comeback

Tennis legend Serena Williams is making waves both on and off the court. As she returns to professional tennis, advertisements featuring her advocacy for GLP-1 medications are set to air, highlighting a significant cultural moment for weight management therapies.

6 min read
GLP-1 Drugs & Your Knees: New Research on Joint Health
Health & Wellness

GLP-1 Drugs & Your Knees: New Research on Joint Health

Discover how GLP-1 medications, known for weight loss, may also significantly reduce the need for knee replacement surgery. This article delves into the latest research and its implications for joint health.

7 min read
Share this article
  1. Home
  2. Blog
  3. Why Silencing Food Noise Requires More Than Ozempic
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community